153 related articles for article (PubMed ID: 33975015)
1. Multi-epitope DnaK peptide vaccine accords protection against lethal S. typhimurium challenge: Elicits both cell mediated immunity and long-lasting serum-neutralizing antibody titers.
Verma S; Singh K; Bansal A
Pharmacol Res; 2021 Jul; 169():105652. PubMed ID: 33975015
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
Pakkanen SH; Kantele JM; Kantele A
Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
[TBL] [Abstract][Full Text] [Related]
3. Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.
Wahid R; Fresnay S; Levine MM; Sztein MB
Mucosal Immunol; 2015 Nov; 8(6):1349-59. PubMed ID: 25872480
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
[TBL] [Abstract][Full Text] [Related]
5. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
Das S; Chowdhury R; Pal A; Okamoto K; Das S
Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
[TBL] [Abstract][Full Text] [Related]
6. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
7. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal immunization of recombinant HSP70 (DnaK) of Salmonella Typhi induces a predominant Th2 response and protective immunity in mice against lethal Salmonella infection.
Paliwal PK; Bansal A; Sagi SS; Sairam M
Vaccine; 2011 Sep; 29(38):6532-9. PubMed ID: 21767594
[TBL] [Abstract][Full Text] [Related]
9. Attenuated
Liu Q; Li P; Luo H; Curtiss R; Kong Q
Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
[No Abstract] [Full Text] [Related]
10. Bacterial ghost cell based bivalent candidate vaccine against Salmonella Typhi and Salmonella Paratyphi A: A prophylactic study in BALB/c mice.
Halder P; Maiti S; Banerjee S; Das S; Dutta M; Dutta S; Koley H
Vaccine; 2023 Sep; 41(41):5994-6007. PubMed ID: 37625993
[TBL] [Abstract][Full Text] [Related]
11. A candidate glycoconjugate vaccine induces protective antibodies in the serum and intestinal secretions, antibody recall response and memory T cells and protects against both typhoidal and non-typhoidal
Haldar R; Dhar A; Ganguli D; Chakraborty S; Pal A; Banik G; Miyoshi SI; Das S
Front Immunol; 2023; 14():1304170. PubMed ID: 38264668
[TBL] [Abstract][Full Text] [Related]
12. Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
Verma S; Sugadev R; Kumar A; Chandna S; Ganju L; Bansal A
Vaccine; 2018 Jun; 36(28):4014-4022. PubMed ID: 29861180
[TBL] [Abstract][Full Text] [Related]
13. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
[TBL] [Abstract][Full Text] [Related]
14. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
[TBL] [Abstract][Full Text] [Related]
15. Status of paratyphoid fever vaccine research and development.
Martin LB; Simon R; MacLennan CA; Tennant SM; Sahastrabuddhe S; Khan MI
Vaccine; 2016 Jun; 34(26):2900-2902. PubMed ID: 27083427
[TBL] [Abstract][Full Text] [Related]
16. Potential of a novel flagellin epitope as a broad-spectrum vaccine candidate against enteric fever.
Vij S; Thakur R; Kumari L; Suri CR; Rishi P
Microb Pathog; 2023 Jan; 174():105936. PubMed ID: 36494021
[TBL] [Abstract][Full Text] [Related]
17. Effect of adjuvants on immune response and protective immunity elicited by recombinant Hsp60 (GroEL) of Salmonella typhi against S. typhi infection.
Bansal A; Paliwal PK; Sagi SS; Sairam M
Mol Cell Biochem; 2010 Apr; 337(1-2):213-21. PubMed ID: 19851830
[TBL] [Abstract][Full Text] [Related]
18. Live oral typhoid vaccine Ty21a induces cross-reactive humoral immune responses against Salmonella enterica serovar Paratyphi A and S. Paratyphi B in humans.
Wahid R; Simon R; Zafar SJ; Levine MM; Sztein MB
Clin Vaccine Immunol; 2012 Jun; 19(6):825-34. PubMed ID: 22492745
[TBL] [Abstract][Full Text] [Related]
19. IgA and IgG1 Specific to Vi Polysaccharide of
Dahora LC; Jin C; Spreng RL; Feely F; Mathura R; Seaton KE; Zhang L; Hill J; Jones E; Alam SM; Dennison SM; Pollard AJ; Tomaras GD
Front Immunol; 2019; 10():2582. PubMed ID: 31781100
[TBL] [Abstract][Full Text] [Related]
20. rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium.
Kaur G; STS C; Nimker C; Bansal A
Cell Mol Immunol; 2015 Jan; 12(1):96-106. PubMed ID: 24858422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
